Skip navigation
Agenda

Tracking Emerging State Price Transparency, Reporting & Disclosure Laws to Ensure Compliance

March 22, 2018
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

THURSDAY, MARCH 22, 2018

7:30

Conference Registration and Continental Breakfast

8:30

Chairperson’s Opening Remarks

Sabrina Yohai
Vice President, Corporate Legal
Vertex Pharmaceuticals

8:45

Exploring the Legal and Enforcement Implications of State Drug Pricing Transparency Laws

8:45-9:30

I In-Depth Review of Current State Drug Pricing Reporting Law Requirements and Interpretations

William A. Sarraille
Partner
Sidley Austin LLP

9:30-10:00

IISpotlight on California SB-17

William A. Sarraille
Partner
Sidley Austin LLP

10:00

Networking and Refreshment Break

10:30

Policy Interactive Panel Discussion Implications of State Drug Pricing Transparency Laws on Policy

MODERATOR:

Speaker, TBA

PANELISTS:

Joanne Chan
Assistant General Counsel
Pharmaceutical Research and Manufacturers of America (PhRMA)

Kristin Manzolillo
Senior Director, Global Policy
Pfizer Inc.

Mark Tyndall
Vice President, Government Affairs
Mallinckrodt Pharmaceuticals

11:30

Legal and Compliance Interactive Panel Discussion The Impact of State Pricing Transparency and Disclosure Legislation on Legal and Compliance Practices

MODERATOR:

Speaker, TBA

PANELISTS:

Debbie A. Walters-Francique
Vice President, Assistant General Counsel
Pfizer Inc

Sabrina Yohai
Vice President, Corporate Legal
Vertex Pharmaceuticals

12:30

Networking Luncheon

1:30

Compliance Policies and Documentation Solutions for State Transparency Reporting Obligations

Speaker, TBA

2:30

Networking and Refreshment Break

3:00

Gift Bans, Sunshine Reporting, Lobbying Registration and Disclosure Requirements — Keeping Track of the Evolving State Law Landscape

4:00

Wrap-Up Roundtable Discussion

MODERATOR:

Speaker, TBA

PANELISTS:

Jonathan Connell, JD, MBA
Senior Counsel
Bristol-Myers Squibb

5:00

Close of Conference

Networking, Wine and Cheese Reception immediately following the final session on day one

Agenda

Want more agenda details? Download the brochure.
Want more agenda details? Download the brochure.

THURSDAY, MARCH 22, 2018

7:30

Conference Registration and Continental Breakfast

8:30

Chairperson’s Opening Remarks

Sabrina Yohai
Vice President, Corporate Legal
Vertex Pharmaceuticals

8:45

Exploring the Legal and Enforcement Implications of State Drug Pricing Transparency Laws

8:45-9:30

I In-Depth Review of Current State Drug Pricing Reporting Law Requirements and Interpretations

William A. Sarraille
Partner
Sidley Austin LLP

9:30-10:00

IISpotlight on California SB-17

William A. Sarraille
Partner
Sidley Austin LLP

10:00

Networking and Refreshment Break

10:30

Policy Interactive Panel Discussion Implications of State Drug Pricing Transparency Laws on Policy

MODERATOR:

Speaker, TBA

PANELISTS:

Joanne Chan
Assistant General Counsel
Pharmaceutical Research and Manufacturers of America (PhRMA)

Kristin Manzolillo
Senior Director, Global Policy
Pfizer Inc.

Mark Tyndall
Vice President, Government Affairs
Mallinckrodt Pharmaceuticals

11:30

Legal and Compliance Interactive Panel Discussion The Impact of State Pricing Transparency and Disclosure Legislation on Legal and Compliance Practices

MODERATOR:

Speaker, TBA

PANELISTS:

Debbie A. Walters-Francique
Vice President, Assistant General Counsel
Pfizer Inc

Sabrina Yohai
Vice President, Corporate Legal
Vertex Pharmaceuticals

12:30

Networking Luncheon

1:30

Compliance Policies and Documentation Solutions for State Transparency Reporting Obligations

Speaker, TBA

2:30

Networking and Refreshment Break

3:00

Gift Bans, Sunshine Reporting, Lobbying Registration and Disclosure Requirements — Keeping Track of the Evolving State Law Landscape

4:00

Wrap-Up Roundtable Discussion

MODERATOR:

Speaker, TBA

PANELISTS:

Jonathan Connell, JD, MBA
Senior Counsel
Bristol-Myers Squibb

5:00

Close of Conference

Networking, Wine and Cheese Reception immediately following the final session on day one